SWE
Toggle navigation
English
Svenska
About Us
The Company
Board & Management
Scientific Advisory Board
Scientific Publications
Events & Mediawatch
Careers
Contact Us
Expanded Access Policy
Type 1 Diabetes
Pipeline
Clinical Trials
Investors
Investor Relations
CEO Comments
Corporate Governance
Press Releases
Financial Reports
Financial Calendar
Skip Navigation Links
No clip specified. Please go to the
Press Releases
main page, or use the search function above.
Share This
select
Facebook
Twitter
LinkedIn
Google Plus
Pinterest
Tumblr
StumbleUpon
Blogger
MySpace
Digg
Reddit
Email
Press Releases
2 mars 2026
American Diabetes Association 86th Scientific Sessions to feature retogatein Phase 3 trial in...
24 februari 2026
Diamyd Medical announces finalization of database for interim analysis in Phase 3 DIAGNODE-3...
9 februari 2026
Diamyd Medical receives Notice of Allowance for key retogatein US patent
Financial Reports
January 28, 2026
Quarterly Report 1 25/26
October 8, 2025
Year-End Report 24/25
June 25, 2025
Quarterly Report 3 24/25
©
Privacy Policy
|
Cookie Policy
|
Expanded Access Policy
Share This Page
select
Facebook
Twitter
LinkedIn
Google Plus
Pinterest
Tumblr
StumbleUpon
Blogger
MySpace
Digg
Reddit
Email
GAD PRODUCTS
Order GAD for preclinical research